Biospectal Partners with Amref Health Africa to Extend Global Access to Blood Pressure Management
Biospectal and Amref Health Africa, the largest health NGO in Africa, today announced the launch of a Mobile Remote Patient Monitoring (MRPM) hypertension management pilot program in Kibera (Nairobi), Kenya, the largest informal settlement in Africa. The first-of-its-kind partnership will
Biospectal Selected as Top 3 Innovation Award Finalist for Swiss Medtech Day on June 14, 2022
We’re at it again! Come visit us in Lausanne, Switzerland on 16 May where Biospectal will present as one of three top innovators by Swiss Healthcare Startups. We’ll present to a select group at SHS Healthcare Madness with Antoine Hubert
Biospectal Wins Coveted Health Innovator Selection @ SXSW 2022
SXSW 2022 has selected Biospectal to join its list of Innovation Award finalists from a huge number of entries for the award ceremony in Austin, TX on 14 March. Come talk with us about our fingertip optical sensing with OptiBP and Biodisc
Biospectal to Debut Biodisc™ and Launch OptiBP for iOS Public Beta at CES 2022
The Biospectal team is excited to announce the debut of Biodisc™, a stand-alone, sleekly-designed, all-in-one, blood pressure monitoring device at CES 2022. Biospectal also plans to announce the public beta launch of Biospectal OptiBP™ for iOS at CES 2022, which
Biospectal OptiBP Named Winner in Fast Company’s First-Ever List of the Next Big Things in Tech
Biospectal SA, the remote patient monitoring biosensing software company, today announced the Biospectal OptiBP™ smartphone blood pressure monitoring app and data platform has been named a winner in the Health category for Fast Company’s Next Big Things in Tech list,
Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink
Today we are happy to announce the closing of a CHF 4.0M($4.3M) round of seed funding led by digital health investor, SeedLink, with additional funding from LabCorp, Athensmed, Swiss based Privilege Ventures and other European and US investors. Biospectal will
Biospectal Announces Two Independent Global Health Research and Validation Studies
We’re proud to announce two independent global research and validation studies which integrate the Biospectal OptiBP™ blood pressure measurement app. Currently underway in four low-resource countries, the studies center on the routine measurement and monitoring of blood pressure, assessment of
Biospectal Wins a Coveted Spot on the Swiss National Mobile Startup Team at MWC Barcelona 2021
We’re excited to announce Biospectal has been chosen as one of 10 companies selected to represent Switzerland on the global stage at MWC Barcelona (June 28–July 1, 2021). We look forward to attending and meeting with top-notch investors and industry
5 Blood Pressure Facts on World Hypertension Day 2021
This year on World Hypertension Day, the theme is “Measure Your Blood Pressure Accurately, Control It, Live Longer.” More than one billion people around the world live with hypertension (high blood pressure), putting them at risk of avoidable medical complications
Biospectal’s OptiBP Smartphone Software Achieves Blood Pressure Cuff Accuracy in Breakthrough Study Published in Scientific Reports in Nature
Scientific Reports in Nature has published the breakthrough results of our in depth research conducted at the University of Lausanne, Switzerland’s CHUV hospital by Professor Patrick Schoettker. Focusing on optical blood pressure sensing using only the fingertip on a smartphone